MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

BACKGROUND: One of the most severe complications of the current COVID-19 pandemic is acute respiratory distress syndrome (ARDS). ARDS is caused by increased amounts of pro-inflammatory cytokines, leading to lung damage and loss of lung function. There are currently no effective therapies for combatt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaspi, Haggai, Semo, Jonathan, Abramov, Nathalie, Dekel, Chen, Lindborg, Stacy, Kern, Ralph, Lebovits, Chaim, Aricha, Revital
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814377/
https://www.ncbi.nlm.nih.gov/pubmed/33468250
http://dx.doi.org/10.1186/s13287-021-02143-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814377/
https://www.ncbi.nlm.nih.gov/pubmed/33468250
http://dx.doi.org/10.1186/s13287-021-02143-w

Ejemplares similares